Personalized Medicine: The Genomic Revolution in Cardiac Care

Click here to view Symposium Highlights (Flash)

Objectives

Despite major advancements in cardiovascular disease, there is much more we need to learn about the individualized needs of patients.  Not all patients need the same tests or will react the same way to treatments.  Personalized medicine is the next step toward more efficient and cost-effective medical care.

On Thursday, October 25, 2007, The George Washington University’s George Washington University Heart & Vascular Institute & the McCormick Genomics Center hosted a symposium to examine the issues and implications around the growing forces of personalized medicine in cardiology.  This symposium is intended to provide a valuable state-of-the-art update on the current status and future directions of the genomics of atherosclerotic cardiovascular disease, heart failure and cardiac arrhythmias, and the potential application to individualizing prevention, diagnosis and treatment for cardiac patients.

Elizabeth Nabel, MD, Director, National Heart, Lung, and Blood Institute delivers the luncheon keynote address:  Genomics & Coronary Artery Disease.  The symposium agenda features luminaries in the field of genomics who will explore the state of cardiovascular genomics and how it relates to clinical practice.  The symposium provides a unique forum to examine the issues and stimulate new ideas around personalized medicine as it relates to personalized cardiovascular care.

Objectives

  • To learn from experts the state of cardiovascular genomics and new directions in genomics cardiovascular research.
  • To learn from experts the state of cardiovascular genomics and how it relates to clinical practice.
  • To provide a forum to examine the issues and stimulate new ideas around personalized medicine as it relates to personalized cardiovascular care.
  • To educate policymakers, government officials, payers and private sector leaders about the state of personalized medicine in cardiology and the implications for the future delivery of cardiac care.
  • To identify the public health and individual health benefits and pitfalls realized by personalized cardiac care, which can be communicated to various publics.

Who Will Want to Attend

This symposium is intended for researchers, cardiologists, policy makers, medical industry and other individuals with an interest in personalized medicine and genomics.

  • Cardiologists
  • Basic and clinical researchers with an interest in cardiovascular genomics
  • Cardiovascular epidemiologists
  • Representatives from Medical Industry; Medical Industry Associations; Government Agencies; Patient advocacy Groups; Venture Capital Firms; Major Corporations
  • Federal and Local Policymakers and Staff

The event was held on October 25, 2007. Click here for the agenda.
Dr. Elizabeth Nabel, Director of the National Heart, Lung, Blood Institute will be the Keynote Speaker. Click here to see her bio.